Ist hexapeptide-67 palmitate in der Schwangerschaft sicher?
No harmonised CLP reproductive classifications found and no SCCS or CIR safety assessment for hexapeptide‑67 palmitate; no peer‑reviewed reproductive/toxicology studies available for this specific ingredient. As a palmitoylated peptide, it is expected to be metabolised to palmitic acid and amino acids (no known reproductive hazard). Given its lipophilicity from the palmitate, low but measurable dermal absorption is plausible for adults (CosIng/PubChem list palmitoyl peptides as cosmetic actives; ECHA has no harmonised reproductive classification).
Pregnancy-safe products containing hexapeptide-67 palmitate
Related ingredients
Frequently asked questions
- Ist hexapeptide-67 palmitate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classifications found and no SCCS or CIR safety assessment for hexapeptide‑67 palmitate; no peer‑reviewed reproductive/toxicology studies available for this specific ingredient. As a palmitoylated peptide, it is expected to be metabolised to palmitic acid and amino acids (no known reproductive hazard). Given its lipophilicity from the palmitate, low but measurable dermal absorption is plausible for adults (CosIng/PubChem list palmitoyl peptides as cosmetic actives; ECHA has no harmonised reproductive classification).
- Ist hexapeptide-67 palmitate während des Stillens sicher?
- Same rationale as pregnancy: no evidence of reproductive or lactation-specific hazard from authoritative sources (no harmonised CLP, no SCCS/CIR assessment, no peer‑reviewed lactation data). Low but measurable systemic exposure from topical use is plausible; no data show transfer into breast milk for this compound specifically.
- Ist hexapeptide-67 palmitate sicher für Babyhaut?
- No infant‑specific toxicity data found. Because palmitoylated peptides can have measurable dermal absorption in adults, infant/child exposure is considered higher due to immature barrier and higher surface‑area‑to‑weight; therefore exposure score increased by +1. No evidence of intrinsic reproductive or developmental hazard specific to the ingredient.
- Wie bewertet VeriMom hexapeptide-67 palmitate?
- VeriMom bewertet hexapeptide-67 palmitate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu hexapeptide-67 palmitate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu hexapeptide-67 palmitate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.
